|
Pharmacoeconomics and Outcomes Research
(full day) 8:00-17:00
Pharmacoeconomics for the Health Care
Decision-Makers
Instructor: Ralph
Crott PhD, MPH,
Health Economist, Health Care Knowledge Center, Brussels, Belgium
Course Description:
This one-day short course is designed to teach clinicians and new researchers
how to incorporate pharmacoeconomic evaluations into study design and data
analysis. Participants will learn how to collect and calculate the costs and
outcomes of different alternatives, and determine the economic impact of
clinical outcomes. The development of prospective and retrospective economic
protocols and data collection sheets will be discussed. Different modeling
techniques will be demonstrated and practiced in case studies. Timing of
pharmacoeconomic evaluations in the drug development process will thereby
receive special attention. Guidelines for optimal conduct of these studies
will be demonstrated and their practical application will be discussed.
From the decision maker’s viewpoint, the way pharmacoeconomic
evaluations can be used in health care policy is demonstrated with real cases.
This course is suitable for those with little or some experience in the
design, collection and analysis of pharmacoeconomic data.
Quality of Life / Patient-Reported
Outcomes / Preference-based Measurement (AM) 8:00-12:00
The Analysis and Interpretation of Quality of Life and Patient
Reported Outcomes
Instructor:
Linda Abetz MA,
Director, Questionnaire Development and Validation, Mapi Values, Bollington,
UK;
Benoit Arnold,
Director, Patient Scales for Clinical Practice, Mapi Values, Lyon, France
Course Description:
This course is designed to provide a
range of methods that may help to solve common problems encountered with
quality of life / patient-reported outcomes. These include an overview of
psychometric validation methods (including a brief overview of Rasch
analysis), missing data analysis techniques, and a variety of methods to
assess minimally clinically important differences. Specific examples will
be used throughout the course and participants will be asked to complete a
short exercise. This course is designed for individuals with little
experience with quality-of-life studies.
Pharmacoeconomics
(AM) 8:00-12:00
Elements of Pharmaceutical Pricing
Instructor:
Jack Mycka,
President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato
Dellamano PhD, President, ValueVector (Value Added Business Strategies),
Milan, Italy
Course Description:
This course is designed to cover the elements of pharmaceutical pricing
decisions. It will cover the issues, information and processes employed and
the role of pharmacoeconomics in helping to shape pricing decisions. This
course will be interactive and is designed for those with some experience in
either
pharmacoeconomics or pharmaceutical pricing.
Quality of
Life / Patient-Reported Outcomes / Preference-based Measurement (PM) 13:00-17:00
Utility Measurements (Preference-Based
Techniques)
Instructor:
Jan
Busschbach PhD, Senior Investigator, Department for Medical
Psychology and Psychotherapy and Erasmus Medical Center, Rotterdam, The
Netherlands; Elly Stolk MSc, Institute for
Medical Technology Assessment (iMTA), Erasmus University Medical Center
Rotterdam, The Netherlands.
Course Description: Utility measurement is a method of determining an
individual's preference for a certain outcome represented by a quantitative
score (utility). During this course, methods for measuring preference-based
outcomes like the standard gamble, time trade-off, and visual analogue scale
will be demonstrated. Utility measurement however is not only about mastering
these techniques; it is about using them in such a way that health care decision
makers can apply the results, for instance in QALY-analyses. For this purpose,
one needs to be aware of shortcomings of the available utility measures and
potential solutions.Furthermore one should be aware of the decision-making
context and the way results are interpreted. To equip participants with
expertise in the field of utility measurement, the most important issues will be
discussed: for instance we will consider
potential insensitivity of generic instruments for particular disease specific
problems, and discuss to what extent adaptation of generic or disease-specific
quality of life instruments may offer a solution. This will be demonstrated with
an exercise. Also the issue of "whose values count: patient values or values
from the general public?" will be discussed. Finally we turn to the
interpretation in the context of resource allocation.
This course is for those with some experience with quality-of-life
measures in health economic evaluation.
Cost Studies (PM) 13:00-17:00
Cost Estimation and
Assessing Financial (Budget) Impact of New Health Care Technologies
Instructor:
Josephine Mauskopf PhD,
Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions,
Research Triangle Park, NC, USA; C.
Daniel Mullins PhD,
Professor and Chair
of Pharmaceutical Health Services Research, University of Maryland, School
of Pharmacy, Baltimore, MD, USA
Course
Description:
This course will describe methods to determine the costs associated with a
health condition and the budget impact of new technologies for that
condition. The course will present incidence and prevalence based costing
strategies. Treatment algorithms and event-based approaches will be
demonstrated for disease-specific costs from different decision-maker
perspectives. Both static and dynamic methods for estimating the budget
impact of adding a new drug to a health plan formulary will be presented. Issues related to imputing missing data
will also be discussed. This course
is designed for those with some experience with pharmacoeconomic analysis.
|
